Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan R Hauser

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Ebiomedicine|November 13, 2020
A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airwaysRamon Lorenzo-Redondo, Hannah H Nam, Scott C Roberts, et al.
Microbiology Spectrum|September 22, 2023
Taxonomic characterization of <i>Pseudomonas hygromyciniae</i> sp. nov., a novel species discovered from a commercially purchased antibioticTimothy L Turner, Sumitra D Mitra, Travis J Kochan, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion systemNicholas O Bowlin, John D Williams, Claire A Knoten, et al.
Plos One|February 3, 2021
The three NADH dehydrogenases of Pseudomonas aeruginosa: Their roles in energy metabolism and links to virulenceTeri N Hreha, Sara Foreman, Ana Duran-Pinedo, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2021
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Karol Sokolowski, Amisha Rana, et al.
BMC Infectious Diseases|July 7, 2022
Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolatesTravis J Kochan, Sophia H Nozick, Rachel L Medernach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Long-term Persistence of an Extensively Drug-Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical CenterNathan B Pincus, Kelly E R Bachta, Egon A Ozer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2019
Natural Clostridioides difficile Toxin Immunization in Colonized InfantsLarry K Kociolek, Robyn O Espinosa, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2022
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosaNathan B Pincus, Monica Rosas-Lemus, Samuel W M Gatesy, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection modelNidhi Singh, Christin M L Jogan, Yanan Zang, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Ebiomedicine|November 13, 2020
A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airwaysRamon Lorenzo-Redondo, Hannah H Nam, Scott C Roberts, et al.
Microbiology Spectrum|September 22, 2023
Taxonomic characterization of <i>Pseudomonas hygromyciniae</i> sp. nov., a novel species discovered from a commercially purchased antibioticTimothy L Turner, Sumitra D Mitra, Travis J Kochan, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion systemNicholas O Bowlin, John D Williams, Claire A Knoten, et al.
Plos One|February 3, 2021
The three NADH dehydrogenases of Pseudomonas aeruginosa: Their roles in energy metabolism and links to virulenceTeri N Hreha, Sara Foreman, Ana Duran-Pinedo, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2021
Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing <i>Klebsiella pneumoniae</i>Yanqin Huang, Karol Sokolowski, Amisha Rana, et al.
BMC Infectious Diseases|July 7, 2022
Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolatesTravis J Kochan, Sophia H Nozick, Rachel L Medernach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Long-term Persistence of an Extensively Drug-Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical CenterNathan B Pincus, Kelly E R Bachta, Egon A Ozer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2019
Natural Clostridioides difficile Toxin Immunization in Colonized InfantsLarry K Kociolek, Robyn O Espinosa, Dale N Gerding, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2022
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosaNathan B Pincus, Monica Rosas-Lemus, Samuel W M Gatesy, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2026
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection modelNidhi Singh, Christin M L Jogan, Yanan Zang, et al.
Pageof 13